Canada Diabetes Care Devices Market Outlook to 2018-Glucose Monitoring and Insulin DeliveryReport Details:Published:Septem...
Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth....
5.3 Insulin Delivery Market, Canada, Segment Contribution (%), 2011 395.4 Insulin Delivery Overall Revenue, (2004-2018) 40...
8.3 Secondary Research 788.4 Primary Research 798.5 Models 798.6 Forecasts 798.7 Expert Panels 808.8 GlobalData Consulting...
Table 21: Insulin Delivery, Canada, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 41Table 22: Insulin Deliver...
2004-2011 22Figure 13: Glucose Monitoring, Canada, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 24Figure 14: ...
Market, 2011 66Figure 40: Eli Lilly and Company, Company Share (%),Canada Diabetes Care Devices Market,2011 67Figure 41: A...
Upcoming SlideShare
Loading in …5
×

Canada Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

97 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
97
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Canada Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

  1. 1. Canada Diabetes Care Devices Market Outlook to 2018-Glucose Monitoring and Insulin DeliveryReport Details:Published:September 2012No. of Pages: 80Price: Single User License – US$2500Canada Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin DeliverySummaryGlobalData’s new report, “Canada Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin Delivery” provides key market data on the Canada Diabetes Care Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within two market categories – Glucose Monitoring and InsulinDelivery. The report also provides company shares and distribution shares data for each of theaforementioned market categories. The report is supplemented with global corporate-level profilesof the key market participants with information on company financials and pipeline products,wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the Canada Diabetes CareDevicesmarket.- Key players covered include Bayer HealthCare AG, LifeScan, Inc., F. Hoffmann-La Roche Ltd.,Eli Lilly and Company, Abbott Laboratories, Novo Nordisk A/S and others.
  2. 2. Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Canada Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/197486-canada-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 51.2 List of Figures 62 Introduction 82.1 What is This Report About? 83 Diabetes Care Devices In Canada 93.1 Diabetes Care Devices, Market Segmentation 93.2 Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018 103.3 Diabetes Care Devices Market, Canada, Revenue Mix ($m), 2011 113.4 Diabetes Care Devices Market, Canada, Category Contribution (%), 2011 123.5 Diabetes Care Devices, Canada, Company Share (2010-2011) 174 Glucose Monitoring In Canada 194.1 Glucose Monitoring, Market Segmentation 194.2 Glucose Monitoring Market, Canada, Revenue Mix ($m), 2011 204.3 Glucose Monitoring Market, Canada, Segment Contribution (%), 2011 214.4 Glucose Monitoring Overall Revenue, (2004-2018) 224.4.1 Blood Glucose Meters, Revenue (2004-2018) 264.5 Glucose Monitoring Overall Volume (2004-2018) 294.5.1 Blood Glucose Meters, Volume (2004-2018) 314.6 Glucose Monitoring Average Price (2004-2018) 334.7 Glucose Monitoring Distribution Share (2010-2011) 344.8 Glucose Monitoring, Canada, Company Share (2010-2011) 355 Insulin Delivery In Canada 375.1 Insulin Delivery, Market Segmentation 375.2 Insulin Delivery Market, Canada, Revenue Mix ($m), 2011 38
  3. 3. 5.3 Insulin Delivery Market, Canada, Segment Contribution (%), 2011 395.4 Insulin Delivery Overall Revenue, (2004-2018) 405.4.1 Insulin Pens, Revenue (2004-2018) 445.4.2 Insulin Pumps, Revenue (2004-2018) 485.5 Insulin Delivery Overall Volume (2004-2018) 505.5.1 Insulin Pens, Volume (2004-2018) 545.5.2 Insulin Pumps, Volume (2004-2018) 585.6 Insulin Delivery Average Price (2004-2018) 605.7 Insulin Delivery Distribution Share (2010-2011) 615.8 Insulin Delivery, Canada, Company Share (2010-2011) 626 Overview of Key Companies in Canada Diabetes Care Devices Market 646.1 Bayer HealthCare AG 646.1.1 Company Overview 646.1.2 Share in the Canada Diabetes Care Devices Market 646.2 LifeScan, Inc. 656.2.1 Company Overview 656.2.2 Share in the Canada Diabetes Care Devices Market 656.3 F. Hoffmann-La Roche Ltd. 666.3.1 Company Overview 666.3.2 Share in the Canada Diabetes Care Devices Market 666.4 Eli Lilly and Company 676.4.1 Company Overview 676.4.2 Share in the Canada Diabetes Care Devices Market 676.5 Abbott Laboratories 686.5.1 Company Overview 686.5.2 Share in the Canada Diabetes Care Devices Market 686.6 Novo Nordisk A/S 696.6.1 Company Overview 696.6.2 Share in the Canada Diabetes Care Devices Market 696.7 Becton, Dickinson and Company 706.7.1 Company Overview 706.8 Sanofi 706.8.1 Company Overview 706.9 Medtronic, Inc. 706.9.1 Company Overview 706.10 Animas Corporation 716.10.1 Company Overview 717 Diabetes Care Devices Market Pipeline Products 728 Appendix 758.1 Definitions of Markets Covered in the Report 768.1.1 Diabetes Care Devices 768.2 Research Methodology 78
  4. 4. 8.3 Secondary Research 788.4 Primary Research 798.5 Models 798.6 Forecasts 798.7 Expert Panels 808.8 GlobalData Consulting 808.9 Currency Conversion 808.10 Contact Us 808.11 Disclaimer 801.1 List of TablesTable 1: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018 10Table 2: Diabetes Care Devices Market, Canada, Category Contribution (%), 2011 12Table 3: Diabetes Care Devices, Canada, Cross-Segment Analysis, 2004-2018 14Table 4: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, Historic, 2004-2011 15Table 5: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 16Table 6: Diabetes Care Devices, Canada, Company Share by Revenue ($m), USD Constant,2010-2011 18Table 7: Glucose Monitoring Market, Canada, Segment Contribution (%), 2011 21Table 8: Glucose Monitoring, Canada, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 23Table 9: Glucose Monitoring, Canada, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 25Table 10: Blood Glucose Meters, Canada, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 27Table 11: Blood Glucose Meters, Canada, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 28Table 12: Glucose Monitoring, Canada, Volume (Units) by Segment, Historic, 2004-2011 29Table 13: Glucose Monitoring, Canada, Volume (Units) by Segment, Forecast, 2011-2018 30Table 14: Blood Glucose Meters, Canada, Volume (Units) by Sub-Segment, Historic, 2004-201131Table 15: Blood Glucose Meters, Canada, Volume (Units) by Sub-Segment, Forecast, 2011-201832Table 16: Glucose Monitoring, Canada, Average Price ($), Historic, 2004-2011 33Table 17: Glucose Monitoring, Canada, Average Price ($), Forecast, 2011-2018 33Table 18: Glucose Monitoring, Canada, Distribution Share by Revenue ($m), USD Constant,2010-2011 34Table 19: Glucose Monitoring, Canada, Company Share by Revenue ($m), USD Constant, 2010-2011 36Table 20: Insulin Delivery Market, Canada, Segment Contribution (%), 2011 39
  5. 5. Table 21: Insulin Delivery, Canada, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 41Table 22: Insulin Delivery, Canada, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 43Table 23: Insulin Pens, Canada, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 45Table 24: Insulin Pens, Canada, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 47Table 25: Insulin Pumps (Traditional Insulin Pumps), Canada, Revenue ($m) USD Constant,Historic, 2004-2011 48Table 26: Insulin Pumps (Traditional Insulin Pumps), Canada, Revenue ($m) USD Constant,Forecast, 2011-2018 49Table 27: Insulin Delivery, Canada, Volume (Units) by Segment, Historic, 2004-2011 51Table 28: Insulin Delivery, Canada, Volume (Units) by Segment, Forecast, 2011-2018 53Table 29: Insulin Pens, Canada, Volume (Units) by Sub-Segment, Historic, 2004-2011 55Table 30: Insulin Pens, Canada, Volume (Units) by Sub-Segment, Forecast, 2011-2018 57Table 31: Insulin Pumps, Canada, Volume (Units), Historic, 2004-2011 58Table 32: Insulin Pumps (Traditional Insulin Pumps), Canada, Volume (Units), Forecast, 2011-2018 59Table 33: Insulin Delivery, Canada, Average Price ($), Historic, 2004-2011 60Table 34: Insulin Delivery, Canada, Average Price ($), Forecast, 2011-2018 60Table 35: Insulin Delivery, Canada, Distribution Share by Revenue ($m), USD Constant, 2010-2011 61Table 36: Insulin Delivery, Canada, Company Share by Revenue ($m), USD Constant, 2010-201163Table 37: Diabetes Care Devices Market Pipeline Products 721.2 List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 9Figure 2: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018 10Figure 3: Diabetes Care Devices Market, Canada, Revenue Mix ($m), 2011 11Figure 4: Diabetes Care Devices Market, Canada, Category Contribution (%), 2011 12Figure 5: Diabetes Care Devices, Canada, Cross-Segment Analysis, 2004-2018 13Figure 6: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, Historic, 2004-2011 15Figure 7: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 16Figure 8: Diabetes Care Devices, Canada, Company Share (%), 2011 17Figure 9: Glucose Monitoring, Market Segmentation 19Figure 10: Glucose Monitoring Market, Canada, Revenue Mix ($m), 2011 20Figure 11: Glucose Monitoring Market, Canada, Segment Contribution (%), 2011 21Figure 12: Glucose Monitoring, Canada, Revenue ($m) USD Constant, by Segment, Historic,
  6. 6. 2004-2011 22Figure 13: Glucose Monitoring, Canada, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 24Figure 14: Blood Glucose Meters, Canada, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 26Figure 15: Blood Glucose Meters, Canada, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 28Figure 16: Glucose Monitoring, Canada, Volume (Units) by Segment, Historic, 2004-2011 29Figure 17: Glucose Monitoring, Canada, Volume (Units) by Segment, Forecast, 2011-2018 30Figure 18: Blood Glucose Meters, Canada, Volume (Units) by Sub-Segment, Historic, 2004-201131Figure 19: Blood Glucose Meters, Canada, Volume (Units) by Sub-Segment, Forecast, 2011-201832Figure 20: Glucose Monitoring, Canada, Company Share (%), 2011 35Figure 21: Insulin Delivery, Market Segmentation 37Figure 22: Insulin Delivery Market, Canada, Revenue Mix ($m), 2011 38Figure 23: Insulin Delivery Market, Canada, Segment Contribution (%), 2011 39Figure 24: Insulin Delivery, Canada, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 40Figure 25: Insulin Delivery, Canada, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 42Figure 26: Insulin Pens, Canada, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 44Figure 27: Insulin Pens, Canada, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 46Figure 28: Insulin Pumps (Traditional Insulin Pumps), Canada, Revenue ($m) USD Constant,Historic, 2004-2011 48Figure 29: Insulin Pumps (Traditional Insulin Pumps), Canada, Revenue ($m) USD Constant,Forecast, 2011-2018 49Figure 30: Insulin Delivery, Canada, Volume (Units) by Segment, Historic, 2004-2011 50Figure 31: Insulin Delivery, Canada, Volume (Units) by Segment, Forecast, 2011-2018 52Figure 32: Insulin Pens, Canada, Volume (Units) by Sub-Segment, Historic, 2004-2011 54Figure 33: Insulin Pens, Canada, Volume (Units) by Sub-Segment, Forecast, 2011-2018 56Figure 34: Insulin Pumps (Traditional Insulin Pumps), Canada, Volume (Units), Historic, 2004-2011 58Figure 35: Insulin Pumps (Traditional Insulin Pumps), Canada, Volume (Units), Forecast, 2011-2018 59Figure 36: Insulin Delivery, Canada, Company Share (%), 2011 62Figure 37: Bayer HealthCare AG, Company Share (%),Canada Diabetes Care Devices Market,2011 64Figure 38: LifeScan, Inc., Company Share (%),Canada Diabetes Care Devices Market, 2011 65Figure 39: F. Hoffmann-La Roche Ltd., Company Share (%),Canada Diabetes Care Devices
  7. 7. Market, 2011 66Figure 40: Eli Lilly and Company, Company Share (%),Canada Diabetes Care Devices Market,2011 67Figure 41: Abbott Laboratories, Company Share (%),Canada Diabetes Care Devices Market, 201168Figure 42: Novo Nordisk A/S, Dickinson and Company, Company Share (%),Canada DiabetesCare Devices Market, 2011 69Contact: sales@reportsandreports.com for more information.

×